Land: Irland
Sprache: Englisch
Quelle: HPRA (Health Products Regulatory Authority)
DOXYCYCLINE (AS DOXYCYCLINE HYCLATE)
Vetpharma Animal Health, S.L.
QJ01AA02
DOXYCYCLINE (AS DOXYCYCLINE HYCLATE)
500(580) mg/g
Granules for oral solution
POM
Fowl - Chicken, Fowl - Turkey, Porcine
Doxycycline
Antibacterial
Authorised
2013-01-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Powdox Doxycycline 500 mg/g powder for use in drinking water for pigs, chickens and turkeys 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One gram contains: ACTIVE SUBSTANCE: Doxycycline 500.0 mg (equivalent to Doxycycline hyclate 580.0 mg) For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Powder for use in drinking water. Yellowish powder. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (fattening pigs after weaning), chickens (broilers, broilers breeders) and turkeys (broilers, breeders). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs (fattening pigs after weaning): treatment of clinical respiratory infections caused by _Mycoplasma hyopneumoniae_ and _Pasteurella multocida _susceptible to doxycycline. Chickens (broilers, broiler breeders) and turkeys (broilers, breeders): treatment of clinical respiratory infections associated with _Mycoplasma gallisepticum _susceptible to doxycycline. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in animals with hepatic dysfunction. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of drinking water, animals should be treated parenterally. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 03/01/2017_ _CRN 7025387_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Inappropriate use of the product may increase the prevalence of bacteria resistant to tetracycline due to the potential for cross resistance. Use of the product should be ba Lesen Sie das vollständige Dokument